The Center for Grassroots Oversight

This page can be viewed at http://www.historycommons.org/context.jsp?item=FDAPanelKetekPneumonia04262001&scale=0


April 26, 2001: FDA Panel Recommends Approval for Ketek to Treat Streptococcus Pneumonia

In a 7 to 3 vote, an FDA advisory panel recommends approving the antibiotic Ketek, also known as telithromycin, for use in treating streptococcus pneumonia. But the panel does not recommend approving it for use against acute chronic bronchitis, sinusitis, or penicillin-resistant or erythromycin-resistant strep. The panel also recommends conducting additional clinical trials to “see if hints of concern… are real or not” about the drug’s potential side affects on the heart and liver. (Associated Press 4/26/2001)


Creative Commons License Except where otherwise noted, the textual content of each timeline is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike